I agree that this site is using cookies. You can find further informations here.
X
Gotteland, J-P
5  results:
Search for persons X
?
1

AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, redu..:

Carboni, S ; Boschert, U ; Gaillard, P...
British Journal of Pharmacology.  153 (2008)  1 - p. 157-163 , 2008
Link: https://doi.org/10.1038/..
 
?
2

Confirmation of the cardiac safety of nolasiban in a random..:

Täubel, J ; Lorch, U ; Spencer, CS...
https://openaccess.sgul.ac.uk/id/eprint/115596/1/Confirmation%20of%20the%20cardiac%20safety%20of%20nolasiban%20in%20a%20randomised%20cohort%20of%20healthy%20female%20volunteers.pdf.  , 2021
Link: https://openaccess.sgul...
 
?
3

Oxytocin receptor antagonists, atosiban and nolasiban, inhi..:

Kim, SH ; Riaposova, L ; Ahmed, H...
Scientific Reports.  , 2019
Link: http://hdl.handle.net/10..
 
?
4

Differential Effects of Oxytocin Receptor Antagonists, Atos..:

Kim, SH ; Pohl, O ; Chollet, A...
MOLECULAR PHARMACOLOGY.  , 2017
Link: http://hdl.handle.net/10..
 
?
5

AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, redu..:

Carboni, S ; Boschert, U ; Gaillard, P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199388.  , 2007
Link: http://www.ncbi.nlm.nih...
 
1-5